期刊文献+

硼卡钠对辐射损伤细胞增殖能力的影响

Effects of BSH on the Proliferation of Cells Irradiated by γ-Ray
原文传递
导出
摘要 目的研究硼卡钠(sodium borocaptate,BSH)对Hela和HIEC细胞辐射后增殖能力的影响。方法用137Csγ射线对BSH作用下的Hela和HIEC细胞进行不同剂量的一次性照射(1Gy,2Gy,4Gy,6Gy,8Gy),剂量率为0.8Gy/min。分别采用四甲基偶氮噻唑蓝(MTT)法检测和细胞克隆形成法检测细胞增殖情况。结果 MTT实验表明0.0036mg/ml~0.1150mg/ml BSH对3Gy照射后细胞具有明显的辐射保护作用(P<0.05);克隆形成实验发现BSH终浓度为0.060mg/ml时,对不同剂量的辐射损伤具有不同程度的保护作用。结论一定浓度的BSH对照后Hela细胞和HIEC细胞具有明显的促进增殖作用。 Objective To study the protective effect of BSH on the proliferation of Hela and HIEC cells irradiated by γ - ray. Methods Hela and HIEC cells which were given BSH ,were exposed to 137Cs 7 - ray one time with the different doses ( 1, 2, 3, 4, 6, 8 Gy) at the dose rate of 0.8 Gy/rain. The proliferation of cells were measured by MTT assay and cell clone formation assay. Results MTT assay showed that BSH has a significant protective effect on cells at the concentration of 0. 0036 mg/ml to 0.1150 mg/ml. Clone formation assay showed that the protective effect of BSH (0.060mg/ml) was different when cells exposed to different doses. Conclusion BSH can increase proliferation of Hela and HIEC cells irradiated by γ- ray.
机构地区 海军医学研究所
出处 《中国辐射卫生》 2012年第3期257-259,共3页 Chinese Journal of Radiological Health
基金 全军计划科研项目(08-3301) 海军医学研究所青年科研基金(08HY21)
关键词 硼卡钠 电离辐射 细胞增殖 MTT法 克隆形成法 Sodium Boroeaptate Radiation Cell Proliferation MTT Assay Clone Formation Assay
  • 相关文献

参考文献9

  • 1Barth RF, Soloway AH, Goodman JH, et al. Boron neutron capture therapy of brain tumors: an emerging therapeutic mo- dality [ J ]. Neurosurgery, 1999,44 ( 3 ) :433 - 450.
  • 2Takagaki M, Oda Y, Miyatake S, et al. Boron neutron cap- ture therapy: preliminary study of BNCT with sodium borocap- rate ( Na2B12 H11 SH) on glioblastoma [ J ]. J Neurooncol, 1997,35(2) :177 - 185.
  • 3Kageji T, Nagahiro S, Matsuzaki K, et al. Boron neutron cap- ture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma - correlation between radiation dose and radiation injury and clinical outcome [ J ]. Int J Radiat Oncol Biol Phys, 2006,65(5) :1 446 - 1 455.
  • 4Wu G, Barth RF, Yang W, et al. Boron containing macro- molecules and nanovehicles as delivery agents for neutron cap- ture therapy[ J]. Anticancer Agents Med Chem, 2006,6 (2) : 167 - 184.
  • 5Suzuki M, Masunaga S, Kinashi Y, et al. Intra - arterial ad- ministration of sodium borocaptate ( BSH )/lipiodol emulsion delivers B - 10 to liver tumors highly selectively for boron neutron capture therapy:experimental studies in the rat liver model[ J]. Int J Radiat Oncol Biol Phys, 2004,59 (1):260 - 266.
  • 6Yoshida F, Matsumura A, Yamamoto T, et al. Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect [ J ]. Cancer Lett, 2004,215 ( 1 ) :61 -67.
  • 7Barth RF. A critical assessment of boron neutron capture ther- apy: an overview[J]. J Neurooncol, 2003,62( 1 -2) :1 -5.
  • 8Barth RF, Coderre JA, Vicente MG, et al. Boron neutron eapture therapy of cancer:current status and future prospects [ J ]. Clin Cancer Res, 2005,11 ( 11 ) :31 987 - 4 002.
  • 9Otersen B, Haritz D, Grochulla F. Binding and distribution of Na2 B12 H11 SH on cellular and subcellular level in tumor tis- sue of glioma patients in boron neutron capture therapy[ J ]. J of Neurooncol, 1997,33:131 - 139.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部